Directory

Sandra L. Kane-Gill, PharmD, MS, FCCM, FCCP, is a Professor of Pharmacy and Therapeutics at the University of Pittsburgh School of Pharmacy. Additionally, she is the current Interim Chair of the Department of Pharmacy and Therapeutics. She has secondary appointments in the School of Medicine in the Clinical Translational Science Institute, Department of Critical Care Medicine and the Department of Biomedical Informatics. She also serves as Professor for the Center for Critical Care Nephrology. In addition to her academic appointments, Dr. Kane-Gill is a Critical Care Medication Safety Pharmacist at the University of Pittsburgh Medical Center in the Department of Pharmacy.

Research Interests: Dr. Kane-Gill’s interests focus on the assessment of clinical, economic and quality outcomes for critically ill patients. Her goal is to build a pharmacovigilance program to identify effective approaches for the detection, prevention, and management of medication errors and adverse drug events as to improve quality of care and patient safety. She led several pharmacoepidemiology evaluations that improved patient safety surveillance systems, prevented medication errors and adverse drug events (ADEs) and used health information technology (clinical decision support systems, telemedicine, simulation) to improve services. She applies implementation science strategies to ensure the adoption of evidence-based medication safety practices. Dr. Kane-Gill is a federally funded researcher serving as Principal Investigator (AHRQ, NIDDK) and Co-Investigator (AHRQ, NCCIH, NLM, Jewish Healthcare Foundation) on several research grants in this area of study.